Clinical Trial Update: Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of octreotide acetate in patients with uncontrolled acromegaly has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• OCTREOTIDE ACETATE (octreotide acetate)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Acromegaly | Phase 3 | Status: COMPLETED | Results posted: 2011-05-17